Natpara Received US FDA Approval to Treat Hypoparathyroidism
The U.S. Food and Drug Administration has okayed Natpara (parathyroid horomone) to manage hypocalcemia (low blood calcium levels) in sufferers
Read more
Clinical Research Society
International Society for Clinical Research and Translational Medicine